Skip to main content
EXACT Therapeutics AS logo

EXACT Therapeutics AS — Investor Relations & Filings

Ticker · EXTX ISIN · NO0010852213 LEI · 2138006ZE5JAL39AGD55 OL Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2021-12-05 Director's Dealing
Country NO Norway
Listing OL EXTX

About EXACT Therapeutics AS

https://www.exact-tx.com/

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing its proprietary technology platform, Acoustic Cluster Therapy (ACT®), for targeted therapeutic enhancement. The ACT® platform uses ultrasound to amplify the effect of co-administered drugs, with a primary focus on oncology. Its biomechanical mode of action increases the local uptake of therapeutics from blood vessels into the surrounding tissue, including across the blood-brain barrier, without requiring drug reformulation. This non-invasive technology is designed to be compatible with standard ultrasound systems. The company's pipeline includes the ENACT study, a Phase 2 trial evaluating ACT® in patients with locally advanced pancreatic cancer, following the completion of the ACTIVATE Phase 1 study in patients with liver metastases.

Recent filings

Filing Released Lang Actions
EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER' concerning several executives (Chair, COO, CSO) acquiring shares in EXACT Therapeutics AS. This type of filing reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). The document is short and contains the transaction details directly, not announcing a separate report.
2021-12-05 English
EXACT THERAPEUTICS AS – PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING – VALG AV NYTT STYREMEDLEM
AGM Information Classification · 99% confidence The document is explicitly titled "PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING" (Minutes of Extraordinary General Meeting) and includes detailed voting results for resolutions concerning the election of a board member and remuneration. This content directly relates to the formal proceedings and outcomes of a shareholder meeting. This aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (or Extraordinary General Meeting, as this is a protocol/minutes document from such a meeting). It is not a general earnings release (ER), a full annual report (10-K), or just a declaration of voting results (DVA), as it is the full official protocol/minutes document itself.
2021-12-03 Norwegian
EXACT THERAPEUTICS AS – PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING – VALG AV NYTT STYREMEDLEM
Board/Management Information Classification · 95% confidence The document is titled 'PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING' (Minutes from Extraordinary General Meeting) and details the proceedings, specifically the election of a new board member (Anders Wold) and the associated remuneration. This content directly relates to the governance and structure of the company's leadership, which falls under Board/Management Information (MANG) or potentially Governance Information (CGR). However, the core event is the meeting itself and the resulting change in the board composition. Since the document explicitly states the election of a new board member and lists the resulting board structure, the most fitting category is Board/Management Information (MANG). It is not a general AGM presentation (AGM-R) or a formal voting result declaration (DVA), but a specific announcement about management composition resulting from a meeting.
2021-12-03 Norwegian
Exact Therapeutics AS Minutes From Extraordinary General Meeting – Appointment Of New Board Member
AGM Information Classification · 99% confidence The document is explicitly titled "PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING" (Minutes of Extraordinary General Meeting) and contains detailed records of proceedings, including the opening, election of the chair, and voting results on matters such as the election of a new board member and approval of remuneration. This content directly corresponds to the documentation generated following a shareholder meeting. The presence of detailed voting results (Appendix 2) and the formal structure confirms it is the official record of the meeting, not just an announcement of it. This aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (or Extraordinary General Meeting, as this is an 'Ekstraordinær generalforsamling').
2021-12-03 English
Exact Therapeutics AS Minutes From Extraordinary General Meeting – Appointment Of New Board Member
AGM Information Classification · 99% confidence The document is titled 'Exact Therapeutics AS Minutes From Extraordinary General Meeting – Appointment Of New Board Member'. It explicitly states that the Extraordinary General Meeting (EGM) was held and that resolutions were passed, including the election of a new Board Member (Anders Wold). The text refers to the 'Minutes from the Meeting' being enclosed/attached. Since the content directly relates to the proceedings and outcomes of a shareholder meeting, specifically concerning board appointments and associated remuneration, it aligns best with the 'AGM Information' category, even though it specifies an EGM rather than an AGM. The code AGM-R covers materials shared during General Meetings. The document is short and announces the results/minutes of the meeting.
2021-12-03 English
To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING" (Notice of Extraordinary General Meeting) and includes details about the date (December 3, 2021), location (video conference), agenda items (election of board member, remuneration), and instructions for attendance and proxy voting. This content directly relates to soliciting shareholder votes and providing necessary information ahead of a general meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it is a notice for a meeting, the primary function described by the content (agenda, voting rights, proxy forms) is soliciting votes, making PSI more specific than a general RPA or AGM-R (which usually implies the meeting materials themselves or the results).
2021-11-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.